ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

TLSI vs YDES // ALTMAN Z-SCORE & DEBT/EQUITY

TriSalus Life Sciences Inc. (NASDAQ) VS. YD Bio Limited (NASDAQ) • 15-METRIC TALLY: TLSI 3 — YDES 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TLSI VS. YDES) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC TLSI YDES SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 84.60% 28.10% +56.50 TLSI /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -20.00% -15.00 YDES /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -7.96% -1.93% -6.03 YDES /fcf-yield <GO>
Operating Margin -59.70% -60.00% +0.30 TLSI /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 53.40% 16.90% +36.50 TLSI /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 13.44 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 38.4 52.3 -13.89 YDES /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $237.7M $415.8M -$178.1M YDES /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR TLSI REV YDES REV TLSI GROSS % YDES GROSS % TLSI FCF YDES FCF
FY 2025 $45.2M $596.8K 84.6% 28.1% -$18.9M -$8.0M
FY 2024 $29.4M $510.4K 86.1% 30.4% -$41.2M -$1.3M
FY 2023 $18.5M $350.1K — — -$50.6M -$55.7K
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TLSI // BETA —
YDES // BETA —